About Neoplas
Neoplas is a company based in Greifswald (Germany) founded in 2005. Neoplas offers products and services including kINPen® VET. Neoplas operates in a competitive market with competitors including Welch Allyn, Kubanda Cryotherapy, IntegriMedical, Vetbiolix and PulseVet, among others.
- Headquarter Greifswald, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neoplas Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$55.82 K (USD), Grant
Apr 30, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neoplas
Neoplas offers a comprehensive portfolio of products and services, including kINPen® VET.
Uses cold plasma to inactivate pathogens and stimulate animal tissue regeneration.
Funding Insights of Neoplas
Investors in Neoplas
Neoplas has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for Neoplas
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neoplas
Investment portfolio details for Neoplas
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neoplas
Detailed financials for Neoplas
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neoplas Comparisons
Peer comparison for Neoplas
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neoplas
Neoplas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Welch Allyn, Kubanda Cryotherapy, IntegriMedical, Vetbiolix and PulseVet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides smart beds, patient monitoring, and care communications for healthcare facilities.
|
|
| Locked | Locked | Locked |
Cryotherapy devices for treating pet cancer are provided.
|
|
| Locked | Locked | Locked |
Needle-free injection systems for pets are developed.
|
|
| Locked | Locked | Locked |
Develops first-in-class drugs for pet conditions including periodontitis and osteoarthritis.
|
|
| Locked | Locked | Locked |
Developer of sound wave based device for pain management
|
Detailed competitors of Neoplas
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neoplas
Complete news archive for Neoplas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neoplas
Neoplas was founded in 2005 and raised its 1st funding round 14 years after it was founded.
Neoplas is headquartered in Greifswald, Germany. It is registered at Greifswald, Mecklenburg-vorpommern, Germany.
Ulrike Sailer is the current CEO of Neoplas.
Provider of cold plasma technology for gentle wound therapy in veterinary medicine. The company offers cold plasma jet kINPen VET that can be applied in a wide range of indications, such as dermatological diseases, acute and chronic wounds.
Neoplas's top competitors include Kubanda Cryotherapy, IntegriMedical and Jeshron Biotech Solutions.
Neoplas offers kINPen® VET.
Neoplas has 1 investor. Key investors include EIC Fund.